United States · FDA National Drug Code directory
DULOXETINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50771-201_5611fb30-bf39-7dae-e063-6294a90a08ed
- Product NDC
- 50771-201
- Form
- CAPSULE, DELAYED RELEASE PELLETS
- Composition / generic term
- DULOXETINE HYDROCHLORIDE
- Labeler
- Yaopharma Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240101
- Source listing expiry
- 20271231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (50771-201-01) · 50771-201-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →